FBB Biomed is a startup based in the United States, most recent round Series-c-plus.
Based in the United States, FBB Biomed is a startup. Its most recent tracked round is Series-c-plus.
FBB Biomed develops an RNA-based analytics platform that uses RNA-seq and AI to provide a blood-based alternative to lumbar puncture for testing and monitoring neurologic diseases. The company is a private Delaware corporation operating out of Iowa and offers its platform for research use.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.